aTYR PHARMA
- Biological Products, Except Diagnostic Substances
- San Diego, California
Compensation history
Top executives at aTYR PHARMA received an average of $1M per person in annual compensation from 2014 to 2023.
Average pay of disclosed executives at aTYR PHARMA
By year
Executives
We found ten executives who work or worked at aTYR PHARMA.
Sanjay Shukla
aTYR PHARMA
Chief Executive Officer
Jill Broadfoot
aTYR PHARMA
Chief Financial Officer
Nancy Denyes
aTYR PHARMA
General Counsel
David King
aTYR PHARMA
Chief Scientific Officer
Ashraf Amanullah
aTYR PHARMA
Former Senior Vice President, Biologics, Development and Manufacturing
John Mendlein
aTYR PHARMA
Chief Executive Officer
Sanuj Ravindran
aTYR PHARMA
Former Chief Business Officer
Melissa Ashlock
aTYR PHARMA
Former Senior Vice President Translational Medicine and Therapeutics
News
aTYR PHARMA CEO Sanjay Shukla's 2023 pay falls 46% to $1.3M
April 5, 2024
aTYR PHARMA CEO Sanjay Shukla's 2021 pay jumps 75% to $1.9M
March 22, 2022
aTYR PHARMA CEO Sanjay Shukla's 2020 pay jumps 63% to $1.1M
March 23, 2021
aTYR PHARMA CEO Sanjay Shukla's 2019 pay falls 52% to $664K
April 2, 2020
aTYR PHARMA CEO Sanjay Shukla's 2018 pay falls 36% to $1.4M
March 28, 2019
About aTYR PHARMA
- Industry classifications
- DivisionManufacturing
- Major groupChemicals And Allied Products
- Industry groupDrugs
- IndustryBiological Products, Except Diagnostic Substances
- Address10240 Sorrento Valley Road, Suite 300, San Diego, California 92121
- Phone8587318389
- Fiscal year endDecember 31
Source: SEC filings on April 5, 2024, March 22, 2022, March 23, 2021, April 2, 2020, March 28, 2019, April 3, 2018, March 30, 2017, and April 12, 2016.